関連する実験動画
Updated: Mar 13, 2026

11:45
Quantifying Agonist Activity at G Protein-coupled Receptors
Published on: December 26, 2011
19.9K
Gタンパク質構成のリガンド依存変調は,薬効性を変化させる
Sebastian George Barton Furness1, Yi-Lynn Liang1, Cameron James Nowell1
1Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences and Department of Pharmacology, Monash University, Parkville, 3052 VIC, Australia.
Cell
|October 11, 2016
まとめ
カルシトニンGタンパク質結合受容体 (GPCRs) に対するリガンドの有効性は,受容体構造だけではなく,Gタンパク質構造にも依存する. この発見は バイアスアゴニズムのメカニズムに 新たな洞察をもたらします
科学分野:
- 分子薬理学
- 生物化学
- 細胞シグナリング
背景:
- Gタンパク質結合受容体 (GPCR) のシグナリングは,細胞のコミュニケーションに不可欠です.
- アゴニストは,GPCRシグナル伝達を差異的に制御し,しばしばリガンド誘発の受容体構成に起因する.
- これらの違いを制御する正確な分子メカニズムは まだ完全に理解されていません
研究 の 目的:
- カルシトニンGPCR (CTR) のリガンド有効性の決定におけるGタンパク質構成の役割を調査する.
- Gタンパク質構成のリガンド依存の変化が,下流のシグナリングイベントにどのように影響するか探求する.
主な方法:
- カルシトニンGPCR (CTR) で研究されたリガンドの有効性.
- GTPの破壊に対するGタンパク質三元複合体の感受性を分析した.
- 評価された受容体結合のGタンパク質ヘテロトリマー構造.
- 測定されたアゴニスト依存の受容体居住時間と第2メッセンジャー蓄積.
主要な成果:
- CTRにおけるリガンドの有効性は,リガンドに依存するGタンパク質構成の変化と相関しています.
- GTPに対する感受性に影響する独特のGタンパク質構成が観察されました.
- 異なるGタンパク質ヘテロトリマーのレジデンス時間と第2メッセンジャー蓄積率は,リガンド型と関連していた.
- これらの発見は,Gタンパク質の構成が有効性の重要な決定因子であることを示しています.
結論:
- リガンドの有効性は,受容体とGタンパク質の形状の両方によって影響されます.
- Gタンパク質の構成ダイナミクスを理解すると,GPCRシグナル伝達に関するより深い洞察が得られます.
- この研究は,バイアスアゴニズムメカニズムの解明に重要な意味を持っています.
さらに関連する動画
関連する概念動画
The Two-State Receptor Model
3.4K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
3.4K
GPCRs Regulate Adenylyl Cylase Activity
8.0K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
8.0K
GPCR Desensitization
8.5K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
8.5K
Ligand-Gated Ion Channel Receptor: Gating Mechanism
4.5K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
4.5K
Drug-Receptor Interactions
8.0K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
8.0K
Activation and Inactivation of G Proteins
12.1K
Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...
12.1K

